3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
4
Biliary Tract Neoplasms
2
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
Malignant Neoplasms of Digestive Organs
1
Klatskin Tumor
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Epstein-Barr Virus Infections
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bile Duct Neoplasms
1
Advanced Biliary Tract Carcinoma
1
Interventions
pembrolizumab
139
Cisplatin
76
Cetuximab
53
Carboplatin
49
Paclitaxel
39
Nivolumab
39
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
tislelizumab
9
Biopsy
9
durvalumab
8
Radiosurgery
8
Albumin-Bound Paclitaxel
8
130-nm albumin-bound paclitaxel
8
Standard of Care
7
Chemoradiotherapy
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Tegafur
×
1 year
×
Clear all
No trials found.